164 related articles for article (PubMed ID: 19703010)
1. CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression.
Richter GH; Mollweide A; Hanewinkel K; Zobywalski C; Burdach S
Scand J Immunol; 2009 Sep; 70(3):206-15. PubMed ID: 19703010
[TBL] [Abstract][Full Text] [Related]
2. Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals.
Pinto LA; Williams MS; Dolan MJ; Henkart PA; Shearer GM
Eur J Immunol; 2000 Jul; 30(7):2048-55. PubMed ID: 10940894
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation.
Baan CC; Balk AH; van Riemsdijk IC; Vantrimpont PJ; Maat AP; Niesters HG; Zondervan PE; van Gelder T; Weimar W
Transplantation; 2003 May; 75(10):1704-10. PubMed ID: 12777860
[TBL] [Abstract][Full Text] [Related]
4. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
Bosque A; Pardo J; Martínez-Lorenzo MJ; Iturralde M; Marzo I; Piñeiro A; Alava MA; Naval J; Anel A
J Leukoc Biol; 2005 Apr; 77(4):568-78. PubMed ID: 15653751
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
Ayroldi E; Zollo O; Cannarile L; D' Adamio F; Grohmann U; Delfino DV; Riccardi C
Blood; 1998 Dec; 92(11):4212-9. PubMed ID: 9834226
[TBL] [Abstract][Full Text] [Related]
7. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
[TBL] [Abstract][Full Text] [Related]
8. Induction of CD4(+)CD25(+)Foxp3(-) regulatory T cells by Thy-1 stimulation of CD4(+) T cells.
Conrad DM; Coombs MR; Furlong SJ; Forward NA; Hoskin DW
Immunol Cell Biol; 2012 Feb; 90(2):248-52. PubMed ID: 21519344
[TBL] [Abstract][Full Text] [Related]
9. Persistent CD3-crosslinking down-regulates interleukin-2 responsiveness in interleukin-2-competent cloned T cells: the possible involvement of protein kinase C.
Landewé RB; Dijkmans BA; Verdonk MJ; Breedveld FC; Daha MR; Miltenburg AM
Scand J Immunol; 1996 Jul; 44(1):45-53. PubMed ID: 8693291
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency.
Lin SJ; Chao HC; Chang KW; Yan DC
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):65-70. PubMed ID: 12877452
[TBL] [Abstract][Full Text] [Related]
11. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
12. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
13. Anti-human CD63 monoclonal antibody COS3A upregulates monocyte-induced IL-10 excretion leading to diminution of CD3-mediated T cell response.
Wansook S; Mahasongkram K; Chruekamlow N; Pata S; Kasinrerk W; Khunkaewla P
Mol Immunol; 2019 Oct; 114():591-599. PubMed ID: 31536880
[TBL] [Abstract][Full Text] [Related]
14. Anti-IL-2 receptor antibody decreases cytokine-induced apoptosis of human renal tubular epithelial cells (TEC).
Wang S; Zhang ZX; Yin Z; Liu W; Garcia B; Huang X; Acott P; Jevnikar AM
Nephrol Dial Transplant; 2011 Jul; 26(7):2144-53. PubMed ID: 21127133
[TBL] [Abstract][Full Text] [Related]
15. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.
Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG
J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss.
Bosque A; Marzo I; Naval J; Anel A
Mol Immunol; 2007 Feb; 44(6):1446-53. PubMed ID: 16806475
[TBL] [Abstract][Full Text] [Related]
17. Effect of Pseudomonas aeruginosa exotoxin A on CD3-induced human T-cell activation.
Michalkiewicz J; Stachowski J; Barth C; Patzer J; Dzierzanowska D; Runowski D; Madalinski K
Immunol Lett; 1998 Apr; 61(2-3):79-88. PubMed ID: 9657258
[TBL] [Abstract][Full Text] [Related]
18. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.
Haeryfar SM; Conrad DM; Musgrave B; Hoskin DW
Immunol Cell Biol; 2005 Aug; 83(4):352-63. PubMed ID: 16033530
[TBL] [Abstract][Full Text] [Related]
19. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
Wu HY; Quintana FJ; Weiner HL
J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells.
Banz A; Pontoux C; Papiernik M
J Immunol; 2002 Jul; 169(2):750-7. PubMed ID: 12097377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
